Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using...
Topic
Travere Scores Accelerated Approval for First Non-Immunosuppressive IgAN Therapeutic | BioSpace,The FDA granted accelerated...
Bionomics Limited Announces Closing of US$5 Million Underwritten Offering of American Depositary Shares in...
BeiGene to Present Final PFS Results from ALPINE Trial Demonstrating Superior PFS for BRUKINSA® Versus...
Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer | BioSpace,Oxford Biomedica Appoints...
Takeda’s Vedolizumab Clears Phase III in aGvHD | BioSpace,Takeda’s vedolizumab met its primary endpoint...
InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Mantle Cell Lymphoma in...
Dermavant Launches First Commercial for VTAMA® (tapinarof) cream, 1% as Part of a National,...
OliX Pharmaceuticals Publishes Preclinical Research Demonstrating OLX104C’s Potential as an Effective Treatment for Hair...
Novocure to Participate in 34th Annual Piper Sandler Healthcare Conference | BioSpace,Novocure to Participate...
Todos Medical to Attend World Antiviral Congress | BioSpace,Todos Medical to Attend World Antiviral...
FDA Approves Apellis' Syfovre as First Treatment for Geographic Atrophy | BioSpace,On Friday, the...
Biosight Launches a Phase 1/2 Clinical Trial of Aspacytarabine in Combination with Venetoclax for...
Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by U.S. FDA...
Acticor Biotech: World’s First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks...
Takeda’s Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by...
Adagene Appoints Cuong Do to Board of Directors and Audit Committee | BioSpace,Adagene Appoints...
Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update |...
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences - November 23, 2022 |...
Kamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022...
